Search Results
Results found for "Montana Molecular"
- Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology
former colleagues and their description of the company was very intriguing: a biology focused, small molecule
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
Good molecules can fail quietly at this stage —not because they’re weak, but because they’re too strong If you’re not designing with persistent enzyme interactions in mind, you’re building risk into your molecule
- Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
class A GPCR-Gi complex structures is observed in CX3CR1, which may correlate with three cholesterol molecules
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
This 28-day trial will test the pharmacokinetics and safety profile of Inversago’s lead molecule, INV
- Chemical signaling regulates axon regeneration via the GPCR-Gqα pathway in Caenorhabditis elegans
Therefore, the ascaroside signaling system provides a unique example of a signaling molecule that regulates C. elegans secretes a family of small-molecule pheromones called ascarosides, which serve various functions
- GPR108 is required for gambogic acid inhibiting NF-κB signaling in cancer
Overall, our findings supported GPR108 as a promising therapeutic target of cancer, and provided a small molecule
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
Keep pushing the boundaries, because your work moves molecules and medicine forward.
- Allosteric modulation of GPCRs: From structural insights to in silico drug discovery
, we provide a systematic analysis of the currently available GPCR structures in complex with small-molecule
- The regulation of PKA signaling in obesity and in the maintenance of metabolic health
PKA facilitates the actions of hormones, neurotransmitters and other signaling molecules that bind G-protein
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
So far, numerous therapeutics targeting GPCRs have been developed, with a focus on small molecules and
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
structure-based technology has passed a key test, in enabling the discovery of orally available small molecules
- Drug Discovery Picks Up the Pace, Stays on Target
They include small molecules that conditionally modulate proteins in their functional state; three-dimensional
- Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors
studied by protein mapping using the FTMap server, which determines the clustering of small organic probe molecules
- Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
approximately 850 GPCRs) has been successfully drugged, and obtaining highly potent and selective small molecules
- GPCR kinase phosphorylation of distal C-tail sites specifies βarrestin1-mediated signaling by...
phosphorylation sites are required for recruitment of the adaptor protein STAM1 (signal-transducing adaptor molecule
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
The development of new CB2-related pharmacological and genetic tools, including the first small molecule
- Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization
parameters of serotonin1A receptors in normal cells are consistent with models describing the diffusion of molecules
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
This talk gave a general idea of what goes into designing small molecule drugs, using state-of-the-art
- Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and...
Pharmacological targeting of cGAS/STING-YAP signaling by both a small-molecule STING agonist, SR-717,
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
this accuracy to synthetic compounds, limiting its utility in drug discovery involving novel drug-like molecules
- Engineered synaptic tools reveal localized cAMP signaling in synapse assembly
Here, we describe new tools, referred to as "SynTAMs" for synaptic targeting molecules, that enable localized
- Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and ...
essential in biology and understanding how cells integrate signals from a variety of information-coding molecules
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
Ambiguous Decision Gates: Molecules advance or stall based on vibes, not criteria.
- Adhesion GPCR Consortium Newsletter - May 2024
This was because, at that time, the neurexins, another family of adhesion molecules that also happened one of my colleagues to join this select group, which was getting together to talk about my favorite molecules
- Why “Displacement” Misleads You: Allosteric Binding Demystified
But in allosteric systems , adding a modulator doesn’t push another molecule off—it transforms the receptor
- Radioligands vs. Fluorescent Ligands: Binding Assays
One of the atoms in the original molecule is replaced by a radionuclide, which emits radiation.
- β2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during..
Adrenergic receptors on B cells and intracellular β2-ADR downstream molecules (G protein-coupled receptor
- Decoding β-Arrestins: from Structure to function
Tissue expression levels of β-Arrestins and their implications in cancer In addition to molecular interactions
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
Originally developed as ultra-bright lanthanide probes, the team realized they could tune these molecules








